Recent histologic studies have shown that indoleamine 2,3-dioxygenase (IDO) is differentially expressed in the pulmonary vasculature in patients with COVID-19, and that IDO1 is predominantly present in lung tissues of patients with early/mild pneumonitis and those suffering from prolonged pneumonia (68). Here, IDO2 is linked to susceptibility to pneumonia measurement.